Drug launch prices are rising, but Benjamin N. Rome, M.D., M.P.H., and colleagues found no evidence manufacturers raised them in response to the Inflation Reduction Act.
What would it mean to treat vision, hearing and dental utilization as population health metrics, the same way we track vaccination rates or chronic disease management gaps?
Naik says a strong recommendation for infliximab and a call for routine pain assessment are the HS guideline changes most likely to change clinical practice.
New guidelines for care of hidradenitis suppurativa advise against radiotherapy for children and adolescents, citing its long-term risks and safer treatment options.
Hidradenitis suppurativa was long thought to be a rare condition, but global data put the prevalence at 1%, says Naik, co-chair of the new AAD-HS Foundation guidelines for the disease.
Jenny Goins, interim head of the National Alliance of Healthcare Purchaser Coalitions, says employers need the same visibility into medical benefits that a new Department of Labor rule gives them into PBM compensation.